IXC.AX · INVEX THERAPEUTICS LTD
Australia · RS rating 84 · As of 2026-10-14
| Price | 0.12 AUD |
|---|---|
| 1-day change | +9.5% |
| RS rating (overall / 1M / 3M / 12M) | 84 / 67 / 82 / 53 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 32 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +20.7% |
| Market cap (USD) | $5.8M |